Source - RNS
RNS Number : 7580J
SalvaRx Group plc
14 September 2016


SalvaRx Group plc


("SalvaRx" or "the Company")


Corporate Video


SalvaRx (LON: SALV), the drug discovery company focused on cancer immunotherapies, is pleased to announce a new corporate video which can be viewed at




This information is provided by RNS
The company news service from the London Stock Exchange